JP2020063221A - Film for patch support body, laminated body, and patch - Google Patents

Film for patch support body, laminated body, and patch Download PDF

Info

Publication number
JP2020063221A
JP2020063221A JP2018197371A JP2018197371A JP2020063221A JP 2020063221 A JP2020063221 A JP 2020063221A JP 2018197371 A JP2018197371 A JP 2018197371A JP 2018197371 A JP2018197371 A JP 2018197371A JP 2020063221 A JP2020063221 A JP 2020063221A
Authority
JP
Japan
Prior art keywords
film
patch
patch support
convex
concavo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018197371A
Other languages
Japanese (ja)
Other versions
JP7275527B2 (en
Inventor
浩介 高柳
Kosuke Takayanagi
浩介 高柳
徹三 ▲崎▼山
徹三 ▲崎▼山
Tetsuzo Sakiyama
愛沙子 藤井
Asako Fujii
愛沙子 藤井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toppan Inc
Original Assignee
Toppan Printing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toppan Printing Co Ltd filed Critical Toppan Printing Co Ltd
Priority to JP2018197371A priority Critical patent/JP7275527B2/en
Publication of JP2020063221A publication Critical patent/JP2020063221A/en
Application granted granted Critical
Publication of JP7275527B2 publication Critical patent/JP7275527B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Laminated Bodies (AREA)

Abstract

To provide a film for a patch support body which satisfies both medicine barrier property and extensibility while suppressing labor and a cost in manufacturing the film, and a laminated body and a patch using the film.SOLUTION: A film 1 for a patch support body is made of resin having medicine barrier property. The entire film is constituted to have a wavy shape in a thickness direction, and thus the film has an uneven structure 12 in which recesses 12A and protrusions 12B are repeated along a surface. The top part of the protrusions 12B and the bottom of the recesses 12A have a flat shape in a cross section. The film thickness of the film 1 for a patch support body is 5 μm or more and 150 μm or less. A height difference H between the recesses and the protrusions is larger than the film thickness of the film 1 for a patch support body.SELECTED DRAWING: Figure 1

Description

本発明は、貼付剤支持体用フィルム、積層体、及び貼付剤に関わるものである。 The present invention relates to a patch support film, a laminate, and a patch.

医療分野等で用いられる貼付剤は、皮膚に貼り付けることで薬剤を経皮吸収させて体内へ取り込ませることを目的とした製剤である。貼付剤はフィルムや不織布の積層体で構成されている。貼付剤の構成の一例として、貼付剤支持体用フィルムを構成する支持体の表面に薬剤と粘着剤を混合した粘着剤層を積層させ、更に粘着剤層の表面に剥離ライナーを積層させた構成のものがある。   The patch used in the medical field and the like is a preparation intended to be percutaneously absorbed and taken into the body by being stuck to the skin. The patch is composed of a laminate of a film and a non-woven fabric. As an example of the structure of a patch, a structure in which a pressure-sensitive adhesive layer in which a drug and a pressure-sensitive adhesive are mixed is laminated on the surface of a support constituting a film for patch patch support and a release liner is further laminated on the surface of the pressure-sensitive adhesive layer. There is one.

ここで支持体に求められる特性として、薬剤バリア性を有すること、伸び性を有すること、等が挙げられる。薬剤バリア性とは、薬剤の経皮吸収を妨げないために支持体が薬剤を吸収しない又は吸収し難い特性のことを指している。本明細書では、温度40℃、湿度75%RHの環境下で1ヶ月保管した際に、支持体の薬剤吸収率が10%未満であれば薬剤バリア性があると定義する。一方で、伸び性は、貼付剤を皮膚に貼り付けた際に突っ張りやごわつきを感じないこと、体を動かした際に貼付剤が剥がれにくくさせること、等のために重要な要素である。本明細書での伸び性とは、支持体が引っ張られた際に降伏点に到達するまでに伸びる比率のことを指している。   Here, the properties required of the support include, for example, having a drug barrier property and having extensibility. The drug barrier property refers to a property that the support does not or hardly absorbs the drug because it does not hinder the transdermal absorption of the drug. In the present specification, when the support has a drug absorption rate of less than 10% when stored in an environment of a temperature of 40 ° C. and a humidity of 75% RH for one month, it is defined as having a drug barrier property. On the other hand, extensibility is an important factor in that the patch does not feel tense or stiff when it is applied to the skin, and that the patch does not easily peel off when the body is moved. The extensibility in the present specification refers to a ratio of elongation when a support is stretched before reaching a yield point.

しかしながら、薬剤バリア性と伸び性を両立させることは困難である場合が多い。薬剤バリア性を有する樹脂は、二軸延伸ポリエチレンテレフタラート(PolyEthylene Terephthalate;PET)、エチレン−ビニルアルコール共重合体(Ethylene−Vinylalcohol copolymer;EVOH)、環状オレフィンコポリマー(Cyclic Olefin Copolymer;COC)などの一部の材料に限定される。これらの材料は一般的に強度が大きく伸び性が低いという欠点がある。   However, it is often difficult to achieve both the drug barrier property and the extensibility. Resins having a drug barrier property include biaxially stretched polyethylene terephthalate (PET), ethylene-vinyl alcohol copolymer (Ethylene-Vinylalcohol copolymer; EVOH), one of cyclic olefin copolymers (Cyclic Olefin Copolymer); COC, etc. Limited to part materials. These materials generally have the drawback of high strength and low extensibility.

このような問題を解決するため、例えば特許文献1では、貼付剤支持体(貼付剤支持体用フィルム)としてPETフィルム等のポリエステル樹脂フィルムを用い、その表面に溝状の切れ目を設けることによって、皮膚に貼り付けた際の追従性を高めた貼付剤を提供している。   In order to solve such a problem, for example, in Patent Document 1, a polyester resin film such as a PET film is used as a patch support (film for patch support), and by providing a groove-like cut on the surface thereof, We provide an adhesive patch with improved followability when applied to the skin.

特許第5349837号公報Japanese Patent No. 5349837

特許文献1の貼付剤の場合、製膜したフィルム表面に微細な溝を加工することとなる。しかし、このような加工には、極めて微妙な機械的あるいは電気的な調整が必要となる。
本発明は、このような課題を解決するためのものであり、薬剤バリア性と伸び性を両立した貼付剤支持体用フィルム、これを用いた積層体や貼付剤を提供することを目的とする。
In the case of the patch of Patent Document 1, fine grooves are processed on the surface of the film formed. However, such processing requires extremely delicate mechanical or electrical adjustment.
The present invention is intended to solve such problems, and an object thereof is to provide a film for patch support that has both drug barrier properties and extensibility, a laminate and a patch using the film. .

課題を解決するために、本発明の一態様は、薬剤バリア性を有する樹脂からなる貼付剤支持体用フィルムであって、フィルム全体が厚さ方向にうねった形状に構成されることで、面に沿って凹部と凸部を繰り返す凹凸構造を有し、上記凸部の頂部及び上記凹部の底部は、それぞれ断面平坦形状となっており、貼付剤支持体用フィルムの膜厚が5μm以上150μm以下であり、上記凹部と上記凸部との高低差が、貼付剤支持体用フィルムの膜厚よりも大きいことを要旨とする。   In order to solve the problems, one embodiment of the present invention is a patch support film made of a resin having a drug barrier property, wherein the entire film is formed in a wavy shape in the thickness direction, Has a concavo-convex structure in which concave portions and convex portions are repeated along the top and bottom portions of the convex portions and the concave portions, respectively, and has a flat cross section, and the thickness of the film for patch support is 5 μm or more and 150 μm or less. The gist is that the height difference between the concave portion and the convex portion is larger than the film thickness of the film for patch support.

本発明の態様によれば、製造時の手間やコストを抑えつつ、薬剤バリア性と伸び性を両立した貼付剤支持体用フィルム、これを用いた積層体や貼付剤を提供することが可能になる。
また、凹凸構造を設けても、凸部の頂部及び上記凹部の底部を断面平坦形状とすることで、凸部及び凹部の延在方向の曲げ剛性を確保しつつ、粘着剤層等の他の層との密着性や凸部の頂部や凹部の底部への印刷適性が向上する。
According to the aspect of the present invention, it is possible to provide a film for a patch support that has both drug barrier properties and extensibility, a laminate and a patch using the same while suppressing the labor and cost during manufacturing. Become.
Further, even if the uneven structure is provided, by making the top of the convex portion and the bottom of the concave portion flat in cross section, while securing bending rigidity in the extending direction of the convex portion and the concave portion, other pressure-sensitive adhesive layers such as The adhesion to the layer and the printability on the top of the convex portion and the bottom of the concave portion are improved.

本発明の貼付剤支持体用フィルムの一実施形態を示した断面図である。It is sectional drawing which showed one Embodiment of the film for adhesive patch supports of this invention. 本発明の貼付剤支持体用フィルムの一実施形態を示した斜視図である。1 is a perspective view showing an embodiment of a film for patch support of the present invention. 本発明に記載の貼付剤支持体用フィルムを引っ張った場合の、フィルム全体の伸びとフィルムに掛かる応力の関係を示した概略図である。FIG. 3 is a schematic diagram showing the relationship between the elongation of the entire film and the stress applied to the film when the film for patch support according to the present invention is pulled. 複数層からなる貼付剤支持体用フィルムの一例を示す断面図である。It is sectional drawing which shows an example of the film for patches support which consists of multiple layers. 本発明の貼付剤支持体用フィルムを用いた積層体の一実施形態を示した断面図である。It is sectional drawing which showed one Embodiment of the laminated body using the film for adhesive patch supports of this invention. 本発明の貼付剤支持体用フィルムを用いた積層体の一実施形態を示した断面図である。It is sectional drawing which showed one Embodiment of the laminated body using the film for adhesive patch supports of this invention. 本発明の貼付剤支持体用フィルムを用いた積層体の一実施形態を示した断面図である。It is sectional drawing which showed one Embodiment of the laminated body using the film for adhesive patch supports of this invention. 一般的な貼付剤の概略を示した断面図である。It is sectional drawing which showed the outline of a general patch. 本発明の貼付剤支持体用フィルムを用いた貼付剤の一実施形態を示した断面図である。FIG. 3 is a cross-sectional view showing an embodiment of a patch using the film for patch support of the present invention. 本発明の貼付剤支持体用フィルムを用いた貼付剤の一実施形態を示した断面図である。FIG. 3 is a cross-sectional view showing an embodiment of a patch using the film for patch support of the present invention. 本発明の貼付剤支持体用フィルムの、複数の区画を有する場合の一実施形態を示した正面図である。It is the front view which showed one Embodiment in the case of having a some division of the film for adhesive patch supports of this invention.

以下に、本発明の実施形態について図面を参照しつつ説明する。
なお、各図は模式的に示した図であり、各部の大きさや形状等は理解を容易にするために適宜誇張して示している。また、本明細書で用いる表面と裏面とは便宜上の記載であり、貼付剤支持体用フィルムにおける一対の面のいずれかを表面及び裏面としても良い。
Embodiments of the present invention will be described below with reference to the drawings.
Note that each drawing is a schematic view, and the size and shape of each portion are exaggerated as appropriate for easy understanding. Further, the front surface and the back surface used in the present specification are descriptions for convenience, and either of the pair of surfaces in the film for patch support may be the front surface and the back surface.

図1及び図2に示す本実施形態の貼付剤支持体用フィルム1は、薬剤バリア性を有する樹脂からなる単層の樹脂製フィルムからなる。貼付剤支持体用フィルム1は、フィルム全体が厚さ方向にうねった形状(蛇行した形状)に構成されることで、フィルムの面に沿って凹部12Aと凸部12Bを周期的に繰り返す凹凸構造12を有する。
凹部12Aと凸部12Bは、凹凸の並び方向と交差する方向に延在している。図2では、凹凸の並び方向と直交方向へ、凹部12Aと凸部12Bが直線状に延在する場合が例示されているが、蛇行しながら延在したり、同心状に延在したりするなど、凹部12Aと凸部12Bの延在パターンの形態(凹凸パターン)に制限はない。
The patch support film 1 of the present embodiment shown in FIGS. 1 and 2 is a single-layer resin film made of a resin having a drug barrier property. The film 1 for patch support has a concavo-convex structure in which concave portions 12A and convex portions 12B are periodically repeated along the surface of the film because the entire film is formed in a wavy shape (meandering shape) in the thickness direction. Have twelve.
The concave portions 12A and the convex portions 12B extend in a direction intersecting the direction in which the irregularities are arranged. Although FIG. 2 exemplifies a case where the concave portions 12A and the convex portions 12B linearly extend in a direction orthogonal to the direction in which the concavities and convexities are arranged, the concave portions 12A and the convex portions 12B extend meanderingly or concentrically. As described above, there is no limitation on the form (concavo-convex pattern) of the extended pattern of the concave portion 12A and the convex portion 12B.

貼付剤支持体用フィルム1は、フィルム全体が厚さ方向に繰り返しうねった形状(蛇行形状)によって、表裏面に周期的な凹凸からなる凹凸構造12を有する。この結果、凹凸の並び方向に、高い伸び性を発現可能となっている。また、凹部12Aと凸部12Bの延在方向の曲げ剛性が向上する。なお、凹凸構造12を設ける領域は、平面視で、貼付剤支持体用フィルム1全面であっても良いし、貼付剤支持体用フィルム1の一部であっても良い。また凹凸構造12を設ける領域を、後述のように複数設けても良い。   The patch support film 1 has a concavo-convex structure 12 consisting of periodic concavities and convexities on the front and back sides, due to the shape (meandering shape) in which the entire film is repeatedly undulated in the thickness direction. As a result, high extensibility can be exhibited in the direction in which the irregularities are arranged. Further, bending rigidity in the extending direction of the concave portion 12A and the convex portion 12B is improved. The area where the concave-convex structure 12 is provided may be the entire surface of the patch support film 1 or a part of the patch support film 1 in plan view. Further, a plurality of regions where the uneven structure 12 is provided may be provided as described later.

また、凸部12Bの頂部12Ba及び凹部12Aの底部12Aaは、それぞれ断面平坦形状(フラット形状)となっている。隣り合う頂部12Baと底部12Aaは、壁部12Cで連結されている、図1では、壁部12Cは膜厚方向に対し傾斜しているため、壁部12Cを斜面部12Cとも呼ぶ。壁部12Cは膜厚方向と同方向に延びるように配置されていても良い。但し、壁部12Cは、隣り合う頂部12Baと底部12Aaとの位置が離れる方向に傾斜した傾斜部となっていることが好ましい。傾斜していることで、フィルムを凹凸の並び方向に引っ張った際に、斜面部12Cと頂部12Ba、および斜面部12Cと底部12Aaの境界部分に応力が集中してフィルムが破断する可能性が抑えられ、凹凸構造12が伸びやすくなる。   Further, the top 12Ba of the protrusion 12B and the bottom 12Aa of the recess 12A each have a flat cross section (flat shape). The adjacent top 12Ba and bottom 12Aa are connected by a wall 12C. In FIG. 1, since the wall 12C is inclined with respect to the film thickness direction, the wall 12C is also referred to as a slope 12C. The wall portion 12C may be arranged so as to extend in the same direction as the film thickness direction. However, it is preferable that the wall portion 12C be an inclined portion that is inclined in a direction in which the positions of the adjacent top portion 12Ba and bottom portion 12Aa are separated. Since the film is inclined, when the film is pulled in the direction in which the concavities and convexities are arranged, the possibility that stress concentrates on the boundary portion between the inclined surface portion 12C and the top portion 12Ba and between the inclined surface portion 12C and the bottom portion 12Aa and the film is prevented from breaking. As a result, the uneven structure 12 is easily stretched.

図1の例では、凹凸構造12は、紙面垂直方向の一縁側(図1中、左端側)から他縁側(図1中、右端側)にわたって、頂部上面2a、斜面部上面2b、底部上面2c及び斜面部上面2bが繰り返し形成されている。また、頂部上面2a、斜面部上面2b、及び底部上面2cにそれぞれ対応する下面3位置に、頂部下面3a、斜面部下面3b、及び底部下面3cを有している。
ここで、図1において、頂部上面2aの幅方向のいずれかの一端(図1では左端)から、隣接する頂部上面2aの幅方向の同じ側の一端までの距離を、貼付剤支持体用フィルム1の凹凸構造12のピッチPと定義する。ピッチPは、隣り合う頂部12Ba間の距離に対応する。ピッチPは、隣り合う頂部12Baの中央部間の距離などであっても良い。
In the example of FIG. 1, the concavo-convex structure 12 extends from one edge side (the left end side in FIG. 1) to the other edge side (the right end side in FIG. 1) in the vertical direction to the top surface 2a, the sloped surface 2b, and the bottom surface 2c. And the upper surface 2b of the slope portion is repeatedly formed. Further, a top lower surface 3a, a slope lower surface 3b, and a bottom lower surface 3c are provided at lower surface 3 positions corresponding to the top upper surface 2a, the slope upper surface 2b, and the bottom upper surface 2c, respectively.
Here, in FIG. 1, the distance from any one end (the left end in FIG. 1) in the width direction of the top surface 2a to the end on the same side in the width direction of the adjacent top surface 2a is the film for the patch support. It is defined as the pitch P of the uneven structure 12 of 1. The pitch P corresponds to the distance between the adjacent tops 12Ba. The pitch P may be a distance between the central portions of the adjacent top portions 12Ba or the like.

また、図1に示すように、凸部2Bが突出する側の面(図1で上面側)での隣り合う凹部12Aの底部2c間の間隔をLと定義する。この間隔Lは、斜面部上面2bと底部上面2cの境界部から、頂部上面2aを挟んで隣接する、斜面部上面2bと底部上面2cの境界部までの距離であって、以下凹凸構造12の幅方向の長さLとも呼ぶ。
さらに、隣り合う凹部12Aと凸部12Bとの、膜厚方向での高低差をHと呼ぶ。高低差Hは、上面2側での高低差Hでも下面3側での高低差Hであっても構わない。すなわち、膜厚方向に沿った、頂部上面2aと底部上面2cの高さ方向の距離又は頂部下面3aと底部下面3cとの高さ方向の距離のいずれかを、高低差Hと定義する。
Further, as shown in FIG. 1, the space between the bottoms 2c of the adjacent recesses 12A on the surface (the upper surface side in FIG. 1) on which the protrusion 2B projects is defined as L. This interval L is the distance from the boundary between the slope upper surface 2b and the bottom upper surface 2c to the boundary between the slope upper surface 2b and the bottom upper surface 2c which are adjacent to each other with the top upper surface 2a interposed therebetween. It is also called the length L in the width direction.
Further, the height difference in the film thickness direction between the adjacent concave portion 12A and convex portion 12B is referred to as H. The height difference H may be the height difference H on the upper surface 2 side or the height difference H on the lower surface 3 side. That is, either the distance in the height direction between the top surface 2a and the bottom surface 2c or the distance between the top surface 3a and the bottom surface 3c in the height direction along the film thickness direction is defined as the height difference H.

図3は、図1のような凹凸構造12のある貼付剤支持体用フィルム1と、凹凸構造12の無いフラットな貼付剤支持体用フィルムを、それぞれ図1の左右方向、すなわち凹凸の並び方向に引っ張った場合の、フィルム全体の伸びと、フィルムに掛かる応力の関係を示した概略図である。
凹凸構造12のある貼付剤支持体用フィルム1を引っ張ると、図3中符号X2のように、主に凹凸構造12が潰れて広がる段階(あまり力を掛けずに伸びる領域)と、上記の潰れた凹凸構造12が更に引き伸ばされてほぼフラットになる段階(力が掛かって延びる領域)を経て降伏点に到達する。更に引っ張り続けると塑性変形が発生し、ネッキングが起こることで最終的に破断点に到達する。ネッキングとは、引っ張られるフィルムの平行部全体が均一に伸びるのではなく、局所的にくびれを生じる現象を指す。
FIG. 3 shows a film 1 for a patch support having a concavo-convex structure 12 as shown in FIG. 1 and a flat film for a patch support without the concavo-convex structure 12 in the left-right direction of FIG. It is the schematic which showed the elongation of the whole film at the time of pulling in, and the relationship of the stress applied to a film.
When the patch support film 1 having the concavo-convex structure 12 is pulled, as shown by reference numeral X2 in FIG. 3, the concavo-convex structure 12 is mainly crushed and spreads (a region that extends without applying much force), and the crush The concavo-convex structure 12 is further stretched and becomes substantially flat (a region where a force is applied and extended) to reach the yield point. If it is further pulled, plastic deformation occurs, and necking occurs, so that the fracture point is finally reached. Necking refers to a phenomenon in which the entire parallel portion of the film to be stretched does not stretch uniformly, but a constriction locally occurs.

一方、凹凸構造12の無いフラットな貼付剤支持体用フィルムを同じ条件で引っ張った場合には、図3中符号X1のように、フィルムが伸び始めてから短い距離でのみ弾性変形が生じ、すぐに降伏点に到達する。更に引っ張り続けると塑性変形が発生し、ネッキングが起こることで破断点に到達する。
このように、本発明に基づく貼付剤支持体用フィルム1は、降伏前に凹凸構造12が潰れて広がることによる伸び量を有するため、通常のフラットな貼付剤支持体用フィルムと比較して降伏点に到達するまでに伸びる量が大きく設定できる。但し、最終的には塑性変形が支配的になるため、破断強度は通常のフラットな貼付剤支持体用フィルムと同等である。
On the other hand, when a flat patch support film without the concavo-convex structure 12 is pulled under the same conditions, elastic deformation occurs only at a short distance after the film starts to grow, as shown by reference numeral X1 in FIG. Reach the yield point. If it is further pulled, plastic deformation occurs and necking occurs to reach the break point.
As described above, the film 1 for patch support according to the present invention has an elongation amount due to the concavo-convex structure 12 being crushed and expanded before yielding, so that it is yielded as compared with a normal flat film for patch support. The amount of expansion before reaching the point can be set large. However, since the plastic deformation finally becomes dominant, the breaking strength is the same as that of a usual flat film for patch support.

このように、本実施形態の貼付剤支持体用フィルム1では、表裏面に周期的な凹凸が形成された凹凸構造12を有することによって、一般的に伸び性が低いとされる材料で貼付剤支持体用フィルムを作製しても、フィルムの伸び性を高めることができる。
貼付剤支持体用フィルム1の膜厚は、5μm以上150μmであると好ましく、より好ましくは10μm以上100μmである。貼付剤支持体用フィルム1の膜厚は必ずしも均一である必要は無く、例えば頂部12Ba、斜面部12C、及び底部12Aaで膜厚がそれぞれ異なっていても良い。
As described above, in the film 1 for patch support of the present embodiment, the patch is made of a material that is generally considered to have low extensibility because it has the concavo-convex structure 12 in which periodic irregularities are formed on the front and back surfaces. Even if a film for a support is produced, the extensibility of the film can be improved.
The thickness of the patch support film 1 is preferably 5 μm or more and 150 μm, and more preferably 10 μm or more and 100 μm. The film thickness for the patch support film 1 does not necessarily have to be uniform, and for example, the top part 12Ba, the slope part 12C, and the bottom part 12Aa may have different film thicknesses.

更に、凹凸構造12の高低差Hは、貼付剤支持体用フィルム1の膜厚Tよりも大きく設計されている。凹凸構造12の高低差Hが膜厚T以下であると、貼付剤支持体用フィルム1の凹凸構造12をフラットな状態に形状変形させることによる、伸びの効果が得られ難い。
高低差Hの上限については300μm以下が好ましい。その理由は、熱プレスや押出成形等の各種方法を用いて貼付剤支持体用フィルム1を製造する際に安定して凹凸構造12を形成させることができるためである。
Further, the height difference H of the concavo-convex structure 12 is designed to be larger than the thickness T of the patch support film 1. If the height difference H of the concavo-convex structure 12 is not more than the film thickness T, it is difficult to obtain the effect of elongation by deforming the concavo-convex structure 12 of the patch support film 1 into a flat state.
The upper limit of the height difference H is preferably 300 μm or less. The reason is that the uneven structure 12 can be stably formed when the patch support film 1 is manufactured by using various methods such as hot pressing and extrusion molding.

貼付剤支持体用フィルム1の材質としては、キャスティング成形、インフレーション成形、熱プレス成形、押出成形、カレンダー成形、などのような所望の製膜方法に適し、かつ所望の薬剤に対するバリア性(薬剤バリア性)を持った樹脂を適宜選択すればよい。すなわち、貼付剤支持体用フィルム1の材料となる樹脂は、貼付剤の使用(用途)で想定される薬剤に対し薬剤バリア性を有する公知の樹脂材料から適宜選択すればよい。
貼付剤支持体用フィルム1の材料としては、例えば、ポリエチレンテレフタラート、シクロオレフィンコポリマー、シクロオレフィンポリマー、ポリアクリロニトリル、エチレン−ビニルアルコール共重合体、及びそれらの変性重合体から選択した樹脂が挙げられる。このような樹脂を用いれば、良好な薬剤バリア性が発現されるため好ましい。このような材料で形成したフィルムは、例えばリバスチグミン、ツロブテロールなどのような薬剤に対し、薬剤バリア性を有する。
The material for the patch support film 1 is suitable for a desired film-forming method such as casting, inflation, hot press molding, extrusion, calender molding, and has a barrier property against a desired drug (drug barrier). The resin having the property) may be appropriately selected. That is, the resin used as the material of the patch support film 1 may be appropriately selected from known resin materials having a drug barrier property against a drug assumed for use (application) of the patch.
Examples of the material of the patch support film 1 include a resin selected from polyethylene terephthalate, cycloolefin copolymer, cycloolefin polymer, polyacrylonitrile, ethylene-vinyl alcohol copolymer, and modified polymers thereof. . The use of such a resin is preferable because a good drug barrier property is exhibited. A film formed of such a material has a drug barrier property against drugs such as rivastigmine and tulobuterol.

また、貼付剤支持体用フィルム1に設ける周期的な凹凸構造12の凹凸形状や凹凸パターンを適切に制御することにより、伸び性や伸びの方向を任意に制御できる。例えば、伸びの量を大きくしたい場合には、凹凸構造12の高低差Hを大きく、ピッチPを小さくする、などの調整を行えば良い。このような調整を行えば、簡易に、貼付剤支持体用フィルム1を形状変形させてフラットな状態に近づけるまでのフィルム1の伸びの量が大きくなり、伸び性を高めることができる。
凹凸構造12の周期的な凹凸は、図1及び図2のような台形形状の繰り返しである必要はなく、矩形形状の繰り返しであっても良い。凸部12Bの頂部12Ba及び凹部12Aの底部12Aaが断面平坦形状な凹凸形状であれば、特に限定されない。
Further, by appropriately controlling the concavo-convex shape and concavo-convex pattern of the periodic concavo-convex structure 12 provided on the patch support film 1, the extensibility and the direction of elongation can be arbitrarily controlled. For example, when it is desired to increase the amount of elongation, adjustment such as increasing the height difference H of the concavo-convex structure 12 and decreasing the pitch P may be performed. If such adjustment is performed, the amount of elongation of the film 1 until the shape of the patch support film 1 is deformed to approach a flat state can be easily increased, and the extensibility can be enhanced.
The periodic unevenness of the uneven structure 12 does not need to be a trapezoidal shape as shown in FIGS. 1 and 2, but may be a rectangular shape. There is no particular limitation as long as the top portion 12Ba of the convex portion 12B and the bottom portion 12Aa of the concave portion 12A have an uneven shape with a flat cross section.

また図1のように、凹凸構造12の断面を観察した場合に、壁部12C(斜面部)の面2b、3bが、断面直線で構成されている必要はなく、折れ線(階段形状など)あるいは曲線で構成されていても良い。但し少なくとも図1及び図2のように、凸部12Bの頂部12Baと凹部12Aの底部12Aaが、壁部12Cを挟みながら交互に形成される。このような形状であれば、凹凸構造12の凹凸の並び方向に引っ張った場合に局所的に応力が集中してその箇所が破断する可能性を抑えつつ、伸び性を高めることができる。
更に図1及び図2のように、頂部上面2aと底部上面2c、及び頂部下面3aと底部下面3cが平行であるような台形形状であることが好ましい。この場合には、後述するように、貼付剤支持体用フィルム1を、熱可塑性樹脂や粘着剤層等のような他の層と積層することで積層体あるいは貼付剤として用いる場合に、貼付剤支持体用フィルム1と他の層との密着性が向上するため、より好ましい。
Further, as shown in FIG. 1, when observing the cross section of the concavo-convex structure 12, the surfaces 2b and 3b of the wall portion 12C (slope surface portion) do not need to be formed by a straight line in cross section, and a polygonal line (step shape, etc.) or It may be composed of a curved line. However, at least as shown in FIGS. 1 and 2, the top portion 12Ba of the convex portion 12B and the bottom portion 12Aa of the concave portion 12A are alternately formed while sandwiching the wall portion 12C. With such a shape, it is possible to improve the extensibility while suppressing the possibility that the stress is locally concentrated and the portion is broken when pulled in the arrangement direction of the unevenness of the uneven structure 12.
Further, as shown in FIGS. 1 and 2, it is preferable that the top surface 2a and the bottom surface 2c are parallel to each other, and the top surface 3a and the bottom surface 3c are parallel to each other. In this case, as will be described later, when the patch support film 1 is used as a laminate or a patch by laminating it with another layer such as a thermoplastic resin or an adhesive layer, the patch It is more preferable because the adhesion between the support film 1 and other layers is improved.

すなわち、凸部12Bの頂部12Ba及び凹部12Aの底部12Aaが断面平坦形状(フラット形状)であることから、貼付剤支持体用フィルム1に他の層を積層する際に、凸部12Bの頂部12Ba及び凹部12Aの底部12Aaと他の層との密着性が向上する。更に、凹凸形状を設けても、凸部12Bの頂部12Ba及び凹部12Aの底部12Aaへのインキの密着性が向上して良好な印刷適性を有するようになる。
なお、貼付剤支持体用フィルム1の凹凸構造12の高低差Hは、5μmより大きく300μm以下であると好ましく、より好ましくは10μm以上200μm以下である。高低差Hが5μm以下の場合には、貼付剤支持体用フィルム1の凹凸構造12をフラットな状態に形状変形させる効果が得られ難く、また300μmを超える凹凸構造12を設けることは製造上困難である。
That is, since the top portion 12Ba of the convex portion 12B and the bottom portion 12Aa of the concave portion 12A have a flat cross-sectional shape (flat shape), when laminating another layer on the patch support film 1, the top portion 12Ba of the convex portion 12B is formed. Also, the adhesion between the bottom portion 12Aa of the recess 12A and other layers is improved. Further, even if the uneven shape is provided, the adhesion of the ink to the top portion 12Ba of the convex portion 12B and the bottom portion 12Aa of the concave portion 12A is improved and good printability is obtained.
The height difference H of the uneven structure 12 of the patch support film 1 is preferably more than 5 μm and 300 μm or less, and more preferably 10 μm or more and 200 μm or less. When the height difference H is 5 μm or less, it is difficult to obtain the effect of deforming the uneven structure 12 of the adhesive patch film 1 into a flat state, and it is difficult to provide the uneven structure 12 exceeding 300 μm in terms of manufacturing. Is.

また、貼付剤支持体用フィルム1において、凹凸構造12の幅方向の長さLに対する高低差Hの比(H/L)は0.10以上1.00以下であると好ましく、より好ましくは0.10以上0.50以下である。幅方向の長さLに対する高低差Hの比(H/L)が1.00よりも大きくなると、凹凸構造12を形成することが製造上困難となり、さらに上面2において頂部上面2a、斜面部上面2b、及び底部上面2cでの膜厚を均一に保つことも困難である。また、幅方向の長さLに対する高低差Hの比(H/L)が0.10よりも小さくなると、凹凸構造12が形状変形することによる伸び性の効果が得られ難い。
また、貼付剤支持体用フィルム1において、上面2における底部上面2cの紙面左右方向の幅W2cに対する、頂部上面2aの紙面左右方向の幅W2aの比(W2a/W2c)が、0.10以上10.0以下であると好ましい。
In the film 1 for patch support, the ratio (H / L) of the height difference H to the length L in the width direction of the concavo-convex structure 12 is preferably 0.10 or more and 1.00 or less, and more preferably 0. 10 or more and 0.50 or less. When the ratio (H / L) of the height difference H to the length L in the width direction is larger than 1.00, it becomes difficult to form the concave-convex structure 12 in manufacturing, and the top surface 2a of the top surface 2 and the slope surface It is also difficult to keep the film thickness on 2b and the bottom surface 2c uniform. Further, if the ratio (H / L) of the height difference H to the length L in the width direction is smaller than 0. 10, it is difficult to obtain the effect of elongation due to the shape deformation of the concavo-convex structure 12.
In the patch support film 1, the ratio (W2a / W2c) of the width W2a of the top surface 2a in the left-right direction of the paper to the width W2c of the top surface 2c in the left-right direction of the paper is 0.10 or more 10 It is preferably less than or equal to 0.0.

幅W2cに対する幅W2aの比(W2a/W2c)が0.10よりも小さい場合、頂部上面2aとその両端で接している斜面部上面2bとの境界部分が近接して存在することとなる。そして、貼付剤支持体用フィルム1の凹凸構造12を並び方向に引っ張った場合、この境界部分に局所的に応力が集中して破断する可能性が高くなる。
また幅W2cに対する幅W2aの比(W2a/W2c)が10.0よりも大きい場合、底部上面2cとその両端で接している斜面部上面2bとの境界部分が近接して存在することとなる。そして、貼付剤支持体用フィルム1の凹凸構造12を並び方向に引っ張った場合、この境界部分に局所的に応力が集中して破断する可能性が高くなる。
When the ratio of the width W2a to the width W2c (W2a / W2c) is smaller than 0. 10, the boundary portion between the top surface 2a and the sloped surface 2b which is in contact with both ends of the top surface 2a is close to each other. When the concavo-convex structure 12 of the patch support film 1 is pulled in the direction in which it is aligned, the stress is locally concentrated on the boundary portion and the possibility of breakage increases.
Further, when the ratio of the width W2a to the width W2c (W2a / W2c) is larger than 10.0, the boundary portion between the bottom surface 2c and the slope surface 2b which is in contact with both ends of the bottom surface 2c is close to each other. When the concavo-convex structure 12 of the patch support film 1 is pulled in the direction in which it is aligned, the stress is locally concentrated on the boundary portion and the possibility of breakage increases.

(製造方法)
本実施形態の貼付剤支持体用フィルム1の製造方法は、例えば熱プレスや押出成形等の各種方法を適宜選択できる。
熱プレスによる方法では、製膜したフィルムを、表面に凹凸形状を設けた一対の加熱ロール間、若しくは一対の加熱した平板状のプレス機に通すことで製造できる。この際、一対の加熱ロール間、若しくは一対の平板の、上下の凹形状と凸形状とを精密に位置合わせを行い、熱プレス後のフィルムの表裏面が連続的な凹凸構造12になっていることが重要となる。
また、押出成形による方法では、樹脂を加熱溶融してTダイから押し出し、フィルム化するための冷却工程において、凹凸形状が設けられた冷却ロール及びニップロールを用いてニップ圧力を付加しながら冷却することで、フィルムの表裏面に連続的な凹凸構造12を設けることができる。この方法においても、冷却ロールとニップロールの凹凸形状の精密な位置合わせが必要になる。
(Production method)
As the method for producing the film 1 for patch support of the present embodiment, various methods such as hot pressing and extrusion molding can be appropriately selected.
In the method by hot pressing, the formed film can be produced by passing it between a pair of heating rolls having an uneven shape on the surface or a pair of heated flat plate presses. At this time, between the pair of heating rolls or between the pair of flat plates, the upper and lower concave shapes and the convex shapes are precisely aligned, and the front and back surfaces of the film after the hot pressing have a continuous uneven structure 12. Is important.
Further, in the extrusion molding method, the resin is heated and melted, extruded from the T-die, and cooled in a cooling step for forming a film by applying a nip pressure using a cooling roll and a nip roll provided with an uneven shape. Then, the concavo-convex structure 12 can be continuously provided on the front and back surfaces of the film. Also in this method, it is necessary to precisely align the uneven shapes of the cooling roll and the nip roll.

あるいは押出成形による別の方法では、複数の押出機を使用し、複数種類の樹脂をフィードブロック法又はマルチマニホールド法により共押出することで、2層以上の多層のフィルムを得ることができる。フィルム化するための冷却工程において、凹凸形状が設けられた冷却ロールを用いてニップ圧力を付加しながら冷却することで、フィルムの表裏面に連続的な凹凸構造12を設けることができる。更にこのとき、冷却ロールと接する第一樹脂層のフィルム膜厚Tに対し、凹凸構造12の高低差Hが大きい場合には、第一樹脂層と第二樹脂層の界面にも同様に凹凸構造12が形成される。このため、冷却後の多層フィルムから第二樹脂層を剥離すれば、表裏面に凹凸構造12が設けられた第一樹脂層が得られ、これを貼付剤支持体用フィルム1として用いることができる。   Alternatively, in another method by extrusion molding, a plurality of extruders are used, and a plurality of types of resins are coextruded by a feed block method or a multi-manifold method, whereby a multilayer film having two or more layers can be obtained. In the cooling step for forming a film, a continuous uneven structure 12 can be provided on the front and back surfaces of the film by cooling while applying a nip pressure using a cooling roll provided with an uneven shape. Further, at this time, when the height difference H of the uneven structure 12 is large with respect to the film thickness T of the first resin layer in contact with the cooling roll, the uneven structure is similarly formed at the interface between the first resin layer and the second resin layer. 12 is formed. Therefore, when the second resin layer is peeled from the cooled multilayer film, a first resin layer having the uneven structure 12 on the front and back surfaces is obtained, which can be used as the patch support film 1. .

その他、キャスティング成形、インフレーション成形、カレンダー成形、などのような種々の方法を適宜選択して貼付剤支持体用フィルム1を製造することが可能である。
貼付剤支持体用フィルム1は、図1及び図2のように一層であっても良い。更に、図4に示すように、共押出の層構成を増やすことで複数の貼付剤支持体用フィルム1を積層した複層構造としても良い。この場合、一方の貼付剤支持体用フィルム1の裏面が、別の貼付剤支持体用フィルム1の表面と接着される。
また貼付剤支持体用フィルム1が三層以上の積層構造であっても良い。これらの場合、貼付剤支持体用フィルム1に対して後工程で、印刷層、蒸着層、ハードコート層、又は反射防止層などの機能層を積層した構造とすることもできる。
In addition, various methods such as casting molding, inflation molding, calender molding, etc. can be appropriately selected to produce the patch support film 1.
The patch support film 1 may be a single layer as shown in FIGS. 1 and 2. Further, as shown in FIG. 4, a multilayer structure in which a plurality of films 1 for patch support is laminated by increasing the layer structure of coextrusion may be used. In this case, the back surface of one film 1 for patch support is bonded to the front surface of another film 1 for patch support.
Further, the patch support film 1 may have a laminated structure of three or more layers. In these cases, a structure in which a functional layer such as a printing layer, a vapor deposition layer, a hard coat layer, or an antireflection layer is laminated on the patch support film 1 in a later step may be used.

図5のように、貼付剤支持体用フィルム1の上面2からなる表面又は下面3からなる裏面のうち少なくともどちらか一方の面に熱可塑性樹脂層5を積層して、積層体4としても良い。図5では、熱可塑性樹脂層5を下面に積層した場合を例示している。積層体4は、別々に製膜した貼付剤支持体用フィルム1と熱可塑性樹脂層5を接着剤や粘着剤を介して積層しても良いし、製膜時に共押出法などで同時に製膜しても良い。熱可塑性樹脂層5を積層した場合、伸び性は若干低減する傾向にある。しかし、熱可塑性樹脂層5は、貼付剤支持体用フィルム1の強度の向上や、酸素バリア性などの機能層としての効果が期待できる。熱可塑性樹脂層5の材料には特に制限は無い。熱可塑性樹脂層5の材料として、例えば低密度ポリエチレン、直鎖状低密度ポリエチレン、又は高密度ポリエチレン等のような弾性率の低い材料を用いれば、貼付剤支持体用フィルム1の伸び性の低減が抑えられるため好ましい。すなわち、熱可塑性樹脂層5は、貼付剤支持体用フィルム1よりも弾性率が低い材料とすることが好ましい。例えば、熱可塑性樹脂層5として、400MPa以下の弾性率の樹脂を使用する。   As shown in FIG. 5, the laminated body 4 may be formed by laminating the thermoplastic resin layer 5 on at least one of the front surface formed by the upper surface 2 and the back surface formed by the lower surface 3 of the patch support film 1. . FIG. 5 illustrates the case where the thermoplastic resin layer 5 is laminated on the lower surface. The laminated body 4 may be formed by laminating the film 1 for adhesive patch support and the thermoplastic resin layer 5 which are separately formed through an adhesive or a pressure-sensitive adhesive, or at the same time by a coextrusion method or the like during film formation. You may. When the thermoplastic resin layer 5 is laminated, the extensibility tends to be slightly reduced. However, the thermoplastic resin layer 5 can be expected to improve the strength of the patch support film 1 and to be effective as a functional layer such as an oxygen barrier property. The material of the thermoplastic resin layer 5 is not particularly limited. When a material having a low elastic modulus such as low density polyethylene, linear low density polyethylene, or high density polyethylene is used as the material of the thermoplastic resin layer 5, the extensibility of the patch support film 1 is reduced. Is suppressed, which is preferable. That is, it is preferable that the thermoplastic resin layer 5 is made of a material having a lower elastic modulus than that of the patch support film 1. For example, as the thermoplastic resin layer 5, a resin having an elastic modulus of 400 MPa or less is used.

更に図6のように、別の貼付剤支持体用フィルム6を、貼付剤支持体用フィルム1と一部に空隙を設けられた状態で積層し、積層体4としても良い。又は、図7のように、接着剤層7を介して、別の貼付剤支持体用フィルム6を、貼付剤支持体用フィルム1と一部に空隙を設けられた状態で積層した積層体4としても良い。これらの場合、熱可塑性樹脂層5及び別の貼付剤支持体用フィルム6の材料には、特定の機能を有する機能性材料を選択することが好ましい。なお、本発明に基づく貼付剤支持体用フィルム1に積層する樹脂は、本発明に基づく貼付剤支持体用フィルム1よりも弾性率が低いことが好ましい。
また図5〜図7のような、本発明に基づく貼付剤支持体用フィルム1を備えた積層体4に、後述する粘着剤層と剥離ライナーを積層することで貼付剤として用いることができる。
Further, as shown in FIG. 6, another patch support film 6 may be laminated with the patch support film 1 in a state where a part of the film is provided to form a laminate 4. Alternatively, as shown in FIG. 7, a laminated body 4 in which another patch film 6 for patch support is laminated with a film 1 for patch support via an adhesive layer 7 in a state in which a gap is provided in a part thereof. Also good. In these cases, it is preferable to select a functional material having a specific function as the material of the thermoplastic resin layer 5 and the other film 6 for the patch support. The resin laminated on the film 1 for patch support according to the present invention preferably has a lower elastic modulus than that of the film 1 for patch support according to the present invention.
Further, it can be used as a patch by laminating a pressure-sensitive adhesive layer and a release liner, which will be described later, on a laminate 4 provided with the film 1 for patch support according to the present invention as shown in FIGS.

図8は、一般的な貼付剤11の概略を示した断面図である。図8の一般的な貼付剤11では、両面がフラットである貼付剤支持体用フィルム8の一方の面に、薬剤を含有した粘着剤層9と剥離ライナー10とをこの順に積層した構成となっている。このような貼付剤11を使用する場合、剥離ライナー10を粘着剤層9から剥がし、粘着剤層9を皮膚に貼り付ける。これにより、粘着剤層9に含まれる薬剤の成分が皮膚から吸収され、薬剤が生体で薬効作用を示す。一般的な貼付剤11を構成している貼付剤支持体用フィルム8は、その表裏面がフラットであるため伸び性に乏しく、皮膚に貼り付けた際に突っ張りやごわつきを感じる、体を動かした際に剥がれ易い、などの課題がある。
これに対して本実施形態の貼付剤支持体用フィルム1、及びこれを用いた積層体4では、従来よりも大きな伸び性を持たせることができる。この結果、皮膚に貼り付けた際に、突っ張りやごわつきを抑制し、且つ体を動かした際に剥がれにくくさせることが可能になる。
FIG. 8: is sectional drawing which showed the outline of the general patch 11. The general patch 11 of FIG. 8 has a structure in which a pressure-sensitive adhesive layer 9 containing a drug and a release liner 10 are laminated in this order on one surface of the patch support film 8 having flat both surfaces. ing. When such a patch 11 is used, the release liner 10 is peeled off from the adhesive layer 9 and the adhesive layer 9 is attached to the skin. As a result, the components of the drug contained in the adhesive layer 9 are absorbed from the skin, and the drug exhibits a medicinal effect in the living body. The film 8 for the patch support, which constitutes the general patch 11, has poor extensibility because its front and back surfaces are flat, and when it is applied to the skin, it feels tense or stiff, and the body was moved. There are problems such as easy peeling.
On the other hand, the patch support film 1 of the present embodiment and the laminate 4 using the same can have greater extensibility than conventional ones. As a result, it becomes possible to suppress bracing and stiffness when it is attached to the skin, and to make it difficult to peel off when the body is moved.

図9及び図10は、本実施形態の貼付剤支持体用フィルム1を用いた貼付剤11の例の概略を示した断面図である。
図9の貼付剤11は、貼付剤支持体用フィルム1の下面に、粘着剤層9と剥離ライナー10をこの順に積層した構成である。更に図10の貼付剤11のように、貼付剤支持体用フィルム1の、粘着剤層9を積層したのとは反対側の面に、更に熱可塑性樹脂層5を積層した積層構造としても良い。
FIG. 9 and FIG. 10 are cross-sectional views showing an outline of an example of the patch 11 using the patch support film 1 of the present embodiment.
The patch 11 of FIG. 9 has a structure in which the pressure-sensitive adhesive layer 9 and the release liner 10 are laminated in this order on the lower surface of the patch support film 1. Further, as a patch 11 in FIG. 10, a laminated structure may be formed by further laminating a thermoplastic resin layer 5 on the surface of the patch support film 1 opposite to the surface on which the adhesive layer 9 is laminated. .

いずれの場合においても、薬剤バリア性の高い材料で貼付剤支持体用フィルム1を製造することで、薬剤の貼付剤支持体用フィルム1への吸収を防ぎ、効率よく皮膚へ吸収させることが可能になる。また貼付剤支持体用フィルム1の表裏面に設けられた凹凸構造12により、伸び性を高くすることが可能になる。
ここで、上記説明では、貼付剤支持体用フィルム1の全面を、凹凸構造12を形成する領域13とした場合を例示しているが、これに限定されない。例えば、凹凸の並び方向(図1では、左右方向)の端部や中央部などに凹凸構造12を形成しないフラット部分を有する構成としても良い。
In any case, by manufacturing the patch support film 1 with a material having a high drug barrier property, it is possible to prevent the drug from being absorbed by the patch support film 1 and efficiently be absorbed into the skin. become. Further, the unevenness structure 12 provided on the front and back surfaces of the patch support film 1 makes it possible to enhance the extensibility.
Here, in the above description, the case where the entire surface of the patch support film 1 is the region 13 in which the concavo-convex structure 12 is formed is illustrated, but the invention is not limited thereto. For example, a configuration may be adopted in which flat portions in which the concave-convex structure 12 is not formed are provided at the end portion or the central portion in the arrangement direction of the irregularities (the horizontal direction in FIG. 1).

また、図11に示すように、貼付剤支持体用フィルム1に、複数の領域13を配置し、各領域13毎に個別の凹凸パターンで上記凹凸構造12を形成するようにしても良い。
図11では、隣り合う領域13を区画する縁(境界線)13aは実線で表されており、個々の領域13内において、頂部上面2aと斜面部上面2bの境界は点線で、底部上面2cと斜面部上面2bの境界は一点鎖線で表されている。
図11では、貼付剤支持体用フィルム1が16個の領域13に区画されており、上面2において、各領域13の一つの縁(「縁端」と呼ぶ)から、これと対向する他の縁端へ頂部上面2a、斜面部上面2b、及び底部上面2cが延在している。なお、下面3においても、頂部下面3a、斜面部下面3b、及び底部下面3cについても同様である(不図示)。
Further, as shown in FIG. 11, a plurality of regions 13 may be arranged in the patch support film 1, and the concavo-convex structure 12 may be formed in each region 13 by an individual concavo-convex pattern.
In FIG. 11, an edge (boundary line) 13a that divides the adjacent regions 13 is represented by a solid line, and in each region 13, the boundary between the top surface 2a and the sloped surface 2b is a dotted line, and the bottom surface 2c is a boundary. The boundary of the upper surface 2b of the inclined surface portion is indicated by a chain line.
In FIG. 11, the patch support film 1 is divided into 16 regions 13, and one edge (referred to as “edge”) of each area 13 on the upper surface 2 is opposite to the other edge. A top surface 2a, a sloped surface 2b, and a bottom surface 2c extend to the edge. The same applies to the lower surface 3 as well (not shown) for the top lower surface 3a, the inclined lower surface 3b, and the bottom lower surface 3c.

また、図11では、隣り合う領域13同士では、互いに凹凸方向の並び方向が異なるように、各領域13での凹凸パターンを設計している。
伸び性が大きなフィルムにおいては、加工時の引っ張りによってフィルムが伸びて安定製膜が難しいという問題点がある。これに対し、図11のように、一枚のフィルムを複数の領域13に区画し、各領域での凹凸パターンを個別に設定することで、貼付剤支持体用フィルム1全体での伸び性が小さく抑えられる。これによって、成形加工時に安定した製膜が可能である。すなわち、凹凸構造12を設けて伸び性を向上させても、貼付剤支持体用フィルム1の製造時や管理時の当該フィルム1のハンドリングが容易となる。
Further, in FIG. 11, the concavo-convex pattern in each of the regions 13 is designed so that the adjacent regions 13 have different concavo-convex arrangement directions.
A film having a large extensibility has a problem that it is difficult to form a stable film because the film is stretched due to pulling during processing. On the other hand, as shown in FIG. 11, by dividing one film into a plurality of regions 13 and individually setting the concavo-convex pattern in each region, the extensibility of the entire patch support film 1 is improved. Can be kept small. This enables stable film formation during molding. That is, even if the concavo-convex structure 12 is provided to improve the extensibility, the film 1 for patch support can be easily handled at the time of production or management.

図11のような貼付剤支持体用フィルム1を、最終製品の原反とし、各領域13毎にカットしたり打ち抜き加工を行ったりすることで、最終製品として所望の一方向へ伸びる貼付剤支持体用フィルム1を得ることができる。
ここで、最終製品は、一領域だけから構成されていなくても良い。例えば、連続した2領域や4領域など複数の領域13で一つの最終製品が構成されていても良い。このとき、各領域13の中央位置でカットして二種類の凹凸構造を有する最終製品としても良い。このような場合、最終製品においては、伸び性が良い方向を2方向以上に設定することが可能となる。
A film 1 for a patch support as shown in FIG. 11 is used as a raw material of a final product, and by cutting or punching each region 13, a patch support that extends in a desired one direction as a final product. The body film 1 can be obtained.
Here, the final product does not have to be composed of only one region. For example, one final product may be composed of a plurality of areas 13 such as continuous two areas and four areas. At this time, the final product having two types of concave and convex structures may be obtained by cutting at the center position of each region 13. In such a case, in the final product, it is possible to set two or more directions in which the extensibility is good.

なお、図11では、同一構造の最終製品を複数製造するための原反としての貼付剤支持体用フィルム1を例示している。また各領域13の輪郭は、矩形である必要は無く、円形など、他の輪郭形状であってもよい。
なお、隣接する領域13同士の境界は明確な境界線13aがなくても良い。また貼付剤支持体用フィルム1が有する領域13の数は任意である。また、図11の貼付剤支持体用フィルム1では、縁端に対して頂部上面2aと斜面部上面2bの境界、及び底部上面2cと斜面部上面2bの境界が平行、又は直交する方向で設けられているが、縁端に対する境界の角度は任意であり、また領域13毎に異なっていても良い。
In addition, in FIG. 11, the patch support film 1 is illustrated as a raw material for producing a plurality of final products having the same structure. Further, the contour of each area 13 does not have to be rectangular, and may be another contour shape such as a circle.
The boundary between the adjacent regions 13 may not have a clear boundary line 13a. Further, the number of regions 13 included in the patch support film 1 is arbitrary. In addition, in the film 1 for patch support of FIG. 11, the boundary between the top surface 2a and the sloped surface 2b, and the boundary between the bottom surface 2c and the sloped surface 2b are parallel or orthogonal to the edge. However, the angle of the boundary with respect to the edge is arbitrary, and may be different for each region 13.

以上、本発明の実施形態について例を挙げて説明したが、本発明はこれらの実施形態に限定されるものではない。また、例を挙げた実施形態を適宜組み合わせて用いることは任意である。   Although the embodiments of the present invention have been described above by way of examples, the present invention is not limited to these embodiments. In addition, it is optional to appropriately combine the exemplary embodiments.

(本実施形態の効果)
(1)本実施形態の貼付剤支持体用フィルムは、薬剤バリア性を有する樹脂からなり、フィルム全体が厚さ方向にうねった形状に構成されることで、面に沿って凹部12Aと凸部12Bを繰り返す凹凸構造12を有し、凸部12Bの頂部12Ba及び凹部12Aの底部12Aaは、それぞれ断面平坦形状となっており、貼付剤支持体用フィルムの膜厚が5μm以上150μm以下であり、凹部12Aと凸部12Bとの高低差Hが、貼付剤支持体用フィルムの膜厚よりも大きい。
この構成によれば、製造時の手間やコストを抑えつつ、薬剤バリア性と伸び性を両立した貼付剤支持体用フィルム、これを用いた積層体及び貼付剤を提供することが可能になる。
また、凹凸構造12を設けても、凸部12Bの頂部12Ba及び上記凹部12Aの底部12Aaを断面平坦形状とすることで、凸部12B及び凹部12Aの延在方向での曲げ剛性を確保しつつ、粘着剤層等の他の層への密着性や、凸部12Bの頂部12Baや凹部12Aの底部12Aaへの印刷適性が向上する。
(Effect of this embodiment)
(1) The film for patch support of the present embodiment is made of a resin having a drug barrier property, and the entire film is formed in a undulating shape in the thickness direction, so that the concave portion 12A and the convex portion are formed along the surface. 12B having a concavo-convex structure 12 repeating, the top 12Ba of the convex 12B and the bottom 12Aa of the concave 12A each have a flat cross section, and the film thickness of the patch support film is 5 μm or more and 150 μm or less, The height difference H between the concave portion 12A and the convex portion 12B is larger than the film thickness of the patch support film.
According to this configuration, it is possible to provide a film for a patch support that has both drug barrier properties and extensibility, a laminate and a patch using the same, while reducing the labor and cost during manufacturing.
Even if the concavo-convex structure 12 is provided, the top portion 12Ba of the convex portion 12B and the bottom portion 12Aa of the concave portion 12A have a flat cross section, so that the bending rigidity in the extending direction of the convex portion 12B and the concave portion 12A is ensured. Adhesion to other layers such as the pressure-sensitive adhesive layer and printability on the top 12Ba of the protrusion 12B and the bottom 12Aa of the recess 12A are improved.

(2)本実施形態の貼付剤支持体用フィルムでは、薬剤バリア性を有する樹脂は、ポリエチレンテレフタラート、シクロオレフィンコポリマー、シクロオレフィンポリマー、ポリアクリロニトリル、エチレン−ビニルアルコール共重合体、及びそれらの変性重合体、のいずれかから選ばれる樹脂である。
この構成によれば、貼付剤支持体用フィルムが確実に薬剤バリア性を有するようになる。
(3)本実施形態の貼付剤支持体用フィルムでは、凸部12Bの頂部12Ba及び上記凹部12Aの底部12Aaは、平行である。
この構成によれば、粘着剤層等の他の層を積層する際の密着性や、凸部12Bの頂部12Baや凹部12Aの底部12Aaへの印刷適性をより確実に向上させることができる。
(2) In the film for patch support of the present embodiment, the resin having a drug barrier property includes polyethylene terephthalate, cycloolefin copolymer, cycloolefin polymer, polyacrylonitrile, ethylene-vinyl alcohol copolymer, and modifications thereof. It is a resin selected from any of polymers.
According to this configuration, the film for patch support surely has the drug barrier property.
(3) In the film for patch support of the present embodiment, the top portion 12Ba of the convex portion 12B and the bottom portion 12Aa of the concave portion 12A are parallel to each other.
According to this configuration, it is possible to more reliably improve the adhesiveness when laminating other layers such as the pressure-sensitive adhesive layer, and the printability on the top 12Ba of the protrusion 12B and the bottom 12Aa of the recess 12A.

(4)本実施形態の貼付剤支持体用フィルムでは、隣り合う上記凸部12Bの頂部12Ba及び上記凹部12Aの底部12Aaを繋ぐ壁部は、フィルムの厚さ方向に対し傾いた斜面部である。
この構成によれば、フィルムを凹凸構造12の並び方向に引っ張った際に、斜面部12Cと頂部12Ba、および斜面部12Cと底部12Aaの境界部分に応力が集中してフィルムが破断する可能性が抑えられ、凹凸構造12が伸びやすくなる。
(5)本実施形態の貼付剤支持体用フィルムでは、凹部12Aと上記凸部12Bとの高低差Hは、5μmより大きく300μm以下である。
この構成によれば、より確実に、伸び性を向上させることができる。
(4) In the film for patch support of the present embodiment, the wall portion connecting the top portion 12Ba of the convex portion 12B and the bottom portion 12Aa of the concave portion 12A that are adjacent to each other is a slope portion inclined with respect to the thickness direction of the film. .
According to this configuration, when the film is pulled in the direction in which the concavo-convex structure 12 is arranged, stress may be concentrated on the boundary portions between the inclined surface portion 12C and the top portion 12Ba and between the inclined surface portion 12C and the bottom portion 12Aa, and the film may be broken. As a result, the uneven structure 12 is easily stretched.
(5) In the film for patch support of the present embodiment, the height difference H between the concave portion 12A and the convex portion 12B is more than 5 μm and 300 μm or less.
According to this configuration, the extensibility can be improved more reliably.

(6)本実施形態の貼付剤支持体用フィルムでは、凸部2Bが突出する側の面での隣り合う凹部2Aの底部12Aa間の間隔Lに対する上記高低差Hの比率(H/L)が、0.10以上1.00以下である。
この構成によれば、凹凸構造12を容易に設けることができ、頂部12Ba、壁部12C、及び底部12Aaでの膜厚を均一に近づけることも容易になる。
(7)本実施形態の貼付剤支持体用フィルムでは、隣り合う上記頂部12Baと上記底部12Aaにおいて、凹凸の並び方向において、上記底部12Aaの幅に対する上記頂部12Baの幅の比率が、0.10以上10.0以下である。
この構成によれば、凹凸構造12を並び方向に引っ張った際における、局所的な応力集中を緩和可能となる。
(6) In the film for patch support of the present embodiment, the ratio (H / L) of the height difference H to the interval L between the bottom portions 12Aa of the adjacent recesses 2A on the surface on which the projections 2B project is , 0.10 or more and 1.00 or less.
According to this structure, the concavo-convex structure 12 can be easily provided, and the film thicknesses of the top portion 12Ba, the wall portion 12C, and the bottom portion 12Aa can be easily made uniform.
(7) In the film for patch support of the present embodiment, the ratio of the width of the top portion 12Ba to the width of the bottom portion 12Aa is 0.10 in the arrangement direction of the unevenness in the adjacent top portion 12Ba and the bottom portion 12Aa. The above is 10.0 or less.
According to this configuration, it is possible to relieve local stress concentration when the concavo-convex structure 12 is pulled in the arrangement direction.

(8)本実施形態の貼付剤支持体用フィルムでは、複数の領域13を有し、各領域13毎に個別の凹凸パターンで上記凹凸構造12が形成されている。
この構成では、最終製品の原反として使用する場合、各領域13の伸びがある程度相殺しあうこことで、過剰な伸びが抑制されて、ロール形状などとして管理する際に、貼付剤支持体用フィルム1の扱いが容易となる。
また、最終製品の貼付剤支持体用フィルム1として使用する場合、伸び易い方向を2方向以上に設定しやすくなる。
(9)貼付剤支持体用フィルムの両面又は片面に、機能層を積層して積層体としても良い。
この構成によれば、伸び性の良い積層体を提供可能となる。
(8) In the film for patch support of the present embodiment, the film has a plurality of regions 13 and each of the regions 13 is formed with the concavo-convex structure 12 in an individual concavo-convex pattern.
With this configuration, when used as a raw material for the final product, the elongations of the respective regions 13 offset each other to some extent, and excessive elongation is suppressed. The film 1 can be easily handled.
Further, when it is used as the film 1 for the patch support of the final product, it is easy to set the easy-to-stretch directions to two or more directions.
(9) A functional layer may be laminated on both surfaces or one surface of the patch support film to form a laminate.
According to this structure, it is possible to provide a laminate having good stretchability.

(10)本実施形態の貼付剤支持体用フィルムを複数枚積層して積層体としても良い。
この構成によれば、例えば薬剤バリア性に特に優れた樹脂からなる貼付剤支持体用フィルムと、伸び特性に優れた貼付剤支持体用フィルムを積層させることで、異なる特性を兼ね備えた積層体を提供可能となる。
(11)本実施形態の貼付剤支持体用フィルムや上記の積層体の両面又は片面に、粘着剤層と剥離ライナー層とをこの順に積層して貼付剤としても良い。
この構成によれば、薬剤バリア性と伸び性を両立した貼付剤を提供することができる。
(10) A plurality of films for the patch support of the present embodiment may be laminated to form a laminate.
According to this configuration, for example, by laminating a patch support film made of a resin having a particularly excellent drug barrier property and a patch support film having excellent elongation properties, a laminate having different properties can be obtained. Can be provided.
(11) A patch may be prepared by laminating an adhesive layer and a release liner layer in this order on both sides or one side of the film for patch support of the present embodiment or the above laminate.
According to this structure, it is possible to provide a patch having both the drug barrier property and the extensibility.

次に本発明に基づく実施例を説明するが、本発明はこれらの実施例に限定されるものではない。
(実施例1)
貼付剤支持体用フィルム1の材料として、日本合成化学工業株式会社製のエチレン−ビニルアルコール共重合体(Ethylene−Vinylalcohol copolymer;EVOH)であるソアノール(登録商標)D2908を選択した。
また、貼付剤支持体用フィルム1と共押出する樹脂の材料として、日本ポリエチレン株式会社製の低密度ポリエチレン(Low Density PolyEthylene;LDPE)であるノバテックLD(登録商標)LC701を選択した。
Next, examples based on the present invention will be described, but the present invention is not limited to these examples.
(Example 1)
Soarnol (registered trademark) D2908 which is an ethylene-vinyl alcohol copolymer (Ethylene-Vinylalcohol copolymer; EVOH) manufactured by Nippon Synthetic Chemical Industry Co., Ltd. was selected as a material of the film 1 for patch support.
In addition, Novatec LD (registered trademark) LC701, which is Low Density PolyEthylene (LDPE) manufactured by Japan Polyethylene Corporation, was selected as a material of the resin coextruded with the film 1 for patch support.

この二種類の樹脂を、押出成形により共押出を行い、その後、フィルム化するための冷却工程において凹凸形状が設けられた冷却ロールを用いてニップ圧力を付加しながら冷却した。その後、共押出した低密度ポリエチレン層を剥離することで、フィルムの表裏面に連続的な凹凸構造12を設けた貼付剤支持体用フィルム1を製造し、実施例1とした。
貼付剤支持体用フィルム1の底部上面2cにおける膜厚は30μmとし、この部分における貼付剤支持体用フィルム1と共押出する樹脂の膜厚は45μmとした。
また凹凸構造12は高低差H100μm、幅方向の長さL236μm、ピッチP425μm、頂部上面2aの左右方向の幅205μmとした。
The two kinds of resins were co-extruded by extrusion molding, and then cooled in a cooling step for forming a film while applying a nip pressure using a cooling roll provided with an uneven shape. Thereafter, the coextruded low density polyethylene layer was peeled off to manufacture a film 1 for patch support having a continuous concavo-convex structure 12 on the front and back surfaces of the film, which was referred to as Example 1.
The film thickness on the bottom surface 2c of the patch support film 1 was 30 μm, and the film thickness of the resin coextruded with the patch support film 1 at this portion was 45 μm.
Further, the uneven structure 12 has a height difference H of 100 μm, a length L236 μm in the width direction, a pitch P425 μm, and a width 205 μm in the left-right direction of the top surface 2a.

(実施例2)
貼付剤支持体用フィルム1の凹凸構造12を高低差H80μm、幅方向の長さL230μm、ピッチP340μmとしたこと以外は、実施例1と同様に貼付剤支持体用フィルム1を製造し、実施例2とした。
(実施例3)
貼付剤支持体用フィルム1の凹凸構造12を高低差H80μm、幅方向の長さL230μm、ピッチP450μmとしたこと以外は、実施例1と同様に貼付剤支持体用フィルム1を製造し、実施例3とした。
(実施例4)
貼付剤支持体用フィルム1の凹凸構造12を高低差H60μm、幅方向の長さL224μm、ピッチP255μmとしたこと以外は、実施例1と同様に貼付剤支持体用フィルム1を製造し、実施例4とした。
(Example 2)
The patch support film 1 was produced in the same manner as in Example 1 except that the uneven structure 12 of the patch support film 1 had a height difference H of 80 μm, a width direction length of L230 μm, and a pitch of P340 μm. It was set to 2.
(Example 3)
A patch support film 1 was produced in the same manner as in Example 1 except that the unevenness structure 12 of the patch support film 1 had a height difference H of 80 μm, a width direction length of L230 μm, and a pitch of P450 μm. It was set to 3.
(Example 4)
The patch support film 1 was produced in the same manner as in Example 1 except that the uneven structure 12 of the patch support film 1 had a height difference H of 60 μm, a width direction length of L224 μm, and a pitch of P255 μm. It was set to 4.

(比較例1)
材料に実施例1と同じEVOHを用い、押出成形でフィルム化するための冷却工程において、凹凸形状の無い平坦な冷却ロールを用いてニップ圧力を付加しながら冷却することで、表裏面が平坦なフィルムを膜厚30μmで製造し、比較例1とした。
(比較例2)
東洋紡株式会社製の二軸延伸ポリエチレンテレフタラート(PolyEthylene Terephthalate;PET)フィルムであるエステルフィルム(登録商標)E5100(膜厚12μm)を比較例2とした。比較例2のフィルムは表裏面が平坦なフィルムである。
(比較例3)
貼付剤支持体用フィルム1の凹凸構造12を高低差H5μm、幅方向の長さL206μm、ピッチP255μmとしたこと以外は、実施例1と同様に貼付剤支持体用フィルム1を製造し、比較例3とした。比較例3のフィルムは、高低差Hが膜厚Tよりも小さいフィルムである。
(Comparative Example 1)
The same EVOH as in Example 1 was used as the material, and in the cooling step for forming a film by extrusion molding, cooling was performed while applying a nip pressure using a flat cooling roll without unevenness, so that the front and back surfaces were flat. A film having a film thickness of 30 μm was produced and was used as Comparative Example 1.
(Comparative example 2)
Comparative Example 2 was an ester film (registered trademark) E5100 (film thickness 12 μm), which is a biaxially oriented polyethylene terephthalate (PET) film manufactured by Toyobo Co., Ltd. The film of Comparative Example 2 is a film whose front and back surfaces are flat.
(Comparative example 3)
A film 1 for patch support was produced in the same manner as in Example 1 except that the uneven structure 12 of the film 1 for patch support was made to have a height difference H5 μm, a length L206 μm in the width direction and a pitch P255 μm. It was set to 3. The film of Comparative Example 3 is a film in which the height difference H is smaller than the film thickness T.

(引っ張り評価)
各実施例の貼付剤支持体用フィルム1、及び各比較例のフィルムの伸び性を評価するため、引っ張り試験を行った。
試験は、株式会社オリエンテック製テンシロン万能試験機(RTC−1250A)を用いて、フィルムが破断するまで引っ張り力を付与して、降伏点及び破断点に到達したときの伸び率(当初のチャック間距離に対する伸び量の比率)を記録した。測定条件は、サンプル幅15mm、チャック間距離50mm、引っ張り速度100mm/minとした。
(Tension evaluation)
In order to evaluate the extensibility of the patch support film 1 of each Example and the films of each Comparative Example, a tensile test was performed.
The test was carried out by using Tensilon Universal Testing Machine (RTC-1250A) manufactured by Orientec Co., Ltd., and applying a tensile force until the film broke, and an elongation percentage when the yield point and the rupture point were reached (the initial chuck interval). The ratio of elongation to distance) was recorded. The measurement conditions were a sample width of 15 mm, a chuck distance of 50 mm, and a pulling speed of 100 mm / min.

(薬剤吸着性試験)
各実施例の貼付剤支持体用フィルム1、及び各比較例のフィルムの薬剤バリア性を評価するため、薬剤吸着性試験を実施した。
各フィルムを100mm角にカットした後、中央に貼付剤を貼付した。貼付剤は、薬剤としてリバスチグミンを含有する小野薬品工業株式会社製リバスタッチ(登録商標)パッチ18mg、及びツロブテロールを含有するマイラン製薬株式会社製ホクナリン(登録商標)テープ2mgを使用した。薬剤が揮発、拡散しないようアルミ箔で密閉し、温度40℃、湿度75%RHの環境下で1ヶ月保管した。その後フィルムから貼付剤を剥がし、フィルムに吸着した薬剤をメタノールで55℃、3時間以上抽出し、高速液体クロマトグラフィーにより薬剤の吸着量を測定した。
(Drug adsorption test)
In order to evaluate the drug barrier properties of the patch support film 1 of each example and the film of each comparative example, a drug adsorption test was carried out.
After each film was cut into 100 mm square, a patch was applied to the center. As the patch, 18 mg of Rivastouch (registered trademark) patch manufactured by Ono Pharmaceutical Co., Ltd. containing rivastigmine as a drug and 2 mg of Hokunarin (registered trademark) tape manufactured by Mylan Pharmaceutical Co., Ltd. containing tulobuterol were used. It was sealed with an aluminum foil so that the chemicals would not volatilize and diffuse, and stored for 1 month in an environment of a temperature of 40 ° C. and a humidity of 75% RH. Thereafter, the patch was peeled off from the film, the drug adsorbed on the film was extracted with methanol at 55 ° C. for 3 hours or more, and the adsorbed amount of the drug was measured by high performance liquid chromatography.

表1に、各実施例の貼付剤支持体用フィルム1、及び各比較例のフィルムの評価結果を示す。   Table 1 shows the evaluation results of the film 1 for patch support of each example and the film of each comparative example.

Figure 2020063221
Figure 2020063221

表1から分かるとおり、本発明に基づく実施例1〜4の貼付剤支持体用フィルム1では、表裏面が平坦な比較例1及び2、ならびに高低差の値が膜厚の値よりも小さい比較例3のフィルムと比較して、引っ張り試験において降伏点に到達したときの伸び率が高い値となり、高い伸び性を有することが確認できた。なお、引っ張り試験において破断点に到達したときの伸び率は、比較例2の平坦なPETフィルムよりは高い値であるが、比較例1の平坦なフィルム、および高低差の値が膜厚の値よりも小さい比較例3のフィルムよりは低い値となった。これは凹凸構造12を設けたことにより、ネッキングが起き易くなったためと考えられる。   As can be seen from Table 1, in the film 1 for patch support of Examples 1 to 4 according to the present invention, Comparative Examples 1 and 2 in which the front and back surfaces are flat, and a comparison in which the height difference value is smaller than the film thickness value As compared with the film of Example 3, the elongation rate at the yield point reached a high value in the tensile test, and it was confirmed that the film had high elongation. The elongation at the time of reaching the breaking point in the tensile test is higher than that of the flat PET film of Comparative Example 2, but the flat film of Comparative Example 1 and the value of the height difference are the film thickness values. The value was lower than the smaller film of Comparative Example 3. It is considered that this is because the provision of the uneven structure 12 facilitated necking.

また実施例1〜4の貼付剤支持体用フィルム1は、リバスチグミン及びツロブテロールのどちらの薬剤についても吸着性を示さず、比較例2のPETフィルムと同等の良好な薬剤バリア性を有することが確認できた。   In addition, the film 1 for patch support of Examples 1 to 4 showed no adsorptivity for both drugs of rivastigmine and tulobuterol, and was confirmed to have good drug barrier properties equivalent to those of the PET film of Comparative Example 2. did it.

本発明の技術を用いることで、製造時の手間やコストを抑えつつ、薬剤バリア性と伸び性を両立した貼付剤支持体用フィルムの製造が可能になる。本発明に記載の貼付剤支持体用フィルムは、医療分野で用いられる貼付剤としての利用が期待できる。   By using the technique of the present invention, it becomes possible to manufacture a film for a patch support which has both drug barrier properties and extensibility while suppressing the labor and cost during the production. The film for patch support of the present invention can be expected to be used as a patch used in the medical field.

1 貼付剤支持体用フィルム
2a 頂部上面
2b 斜面部上面
2c 底部上面
3a 頂部下面
3b 斜面部下面
3c 底部下面
4 積層体
5 熱可塑性樹脂層
6 貼付剤支持体用フィルム
7 接着剤層
8 貼付剤支持体用フィルム
9 粘着剤層
10 剥離ライナー
11 貼付剤
12 凹凸構造
12A 凹部
12Aa 底部
12B 凸部
12Ba 頂部
12C 壁部(斜面部)
13 領域
13a 縁(境界)
H 高低差
P ピッチ
L 幅方向の長さ
1 Film for Patch Support 2a Top Top 2b Slope Top 2c Bottom Top 3a Top Bottom 3b Top Bottom 3c Bottom Bottom 3c Bottom Bottom 4 Laminate 5 Thermoplastic Resin Layer 6 Patch Support Film 7 Adhesive Layer 8 Patch Support Body film 9 Adhesive layer 10 Release liner 11 Patch 12 Concavo-convex structure 12A Recess 12Aa Bottom 12B Convex 12Ba Top 12C Wall (slope)
13 Area 13a Edge (boundary)
H Height difference P Pitch L Length in width direction

Claims (12)

薬剤バリア性を有する樹脂からなる貼付剤支持体用フィルムであって、
フィルム全体が厚さ方向にうねった形状に構成されることで、面に沿って凹部と凸部を繰り返す凹凸構造を有し、
上記凸部の頂部及び上記凹部の底部は、それぞれ断面平坦形状となっており、
貼付剤支持体用フィルムの膜厚が5μm以上150μm以下であり、
上記凹部と上記凸部との高低差が、貼付剤支持体用フィルムの膜厚よりも大きい
ことを特徴とする貼付剤支持体用フィルム。
A film for a patch support comprising a resin having a drug barrier property,
Since the entire film is formed in a wavy shape in the thickness direction, it has a concavo-convex structure in which concaves and convexes are repeated along the surface,
The top portion of the convex portion and the bottom portion of the concave portion each have a flat cross section,
The film thickness for the patch support is 5 μm or more and 150 μm or less,
The film for adhesive patch support, wherein the height difference between the concave portion and the convex portion is larger than the film thickness of the film for adhesive patch support.
上記薬剤バリア性を有する樹脂は、ポリエチレンテレフタラート、シクロオレフィンコポリマー、シクロオレフィンポリマー、ポリアクリロニトリル、エチレン−ビニルアルコール共重合体、及びそれらの変性重合体、のいずれかから選ばれる樹脂であることを特徴とする請求項1に記載の貼付剤支持体用フィルム。   The resin having the drug barrier property is a resin selected from polyethylene terephthalate, cycloolefin copolymer, cycloolefin polymer, polyacrylonitrile, ethylene-vinyl alcohol copolymer, and modified polymers thereof. The film for patch support according to claim 1, which is characterized in that. 上記凸部の頂部及び上記凹部の底部は、平行であることを特徴とする請求項1又は2に記載の貼付剤支持体用フィルム。   The film for a patch support according to claim 1 or 2, wherein the top of the protrusion and the bottom of the recess are parallel to each other. 隣り合う上記凸部の頂部及び上記凹部の底部を繋ぐ壁部は、フィルムの厚さ方向に対し傾いた斜面部であることを特徴とする請求項1〜請求項3のいずれか1項に記載の貼付剤支持体用フィルム。   The wall part connecting the top part of the said convex part and the bottom part of the said recessed part which are adjacent is a slope part inclined with respect to the thickness direction of a film, The claim | item 1 characterized by the above-mentioned. Film for adhesive patch support. 上記凹部と上記凸部との高低差は、5μmより大きく300μm以下であることを特徴とする請求項1〜請求項4のいずれか1項に記載の貼付剤支持体用フィルム。   The difference in height between the concave portion and the convex portion is more than 5 μm and 300 μm or less, and the film for patch support according to any one of claims 1 to 4. 上記凸部が突出する側の面での隣り合う上記凹部の上記底部間の間隔Lに対する上記高低差Hの比率(H/L)が、0.10以上1.00以下であることを特徴とする請求項1〜請求項5のいずれか1項に記載の貼付剤支持体用フィルム。   The ratio (H / L) of the height difference H to the distance L between the bottoms of the adjacent recesses on the surface on which the protrusions protrude is 0.10 or more and 1.00 or less. The film for patch support according to any one of claims 1 to 5. 隣り合う上記頂部と上記底部において、凹凸の並び方向において、上記底部の幅に対する上記頂部の幅の比率が、0.10以上10.0以下であることを特徴とする請求項1〜請求項6のいずれか1項に記載の貼付剤支持体用フィルム。   The ratio of the width of the top to the width of the bottom is 0.10 or more and 10.0 or less in the direction in which the unevenness is arranged between the top and the bottom adjacent to each other. The film for patch support according to any one of 1. 複数の領域を有し、各領域毎に個別の凹凸パターンで上記凹凸構造が形成されていることを特徴とする請求項1〜請求項7のいずれか1項に記載の貼付剤支持体用フィルム。   The patch film for a patch according to any one of claims 1 to 7, wherein the film has a plurality of areas, and the uneven structure is formed in each area with an individual uneven pattern. . 請求項1〜請求項8のいずれか1項に記載された貼付剤支持体用フィルムの両面又は片面に、機能層を積層した積層体。   A laminate in which a functional layer is laminated on both sides or one side of the film for patch support according to any one of claims 1 to 8. 請求項1〜請求項8のいずれか1項に記載された貼付剤支持体用フィルムを複数枚積層した積層体。   A laminate comprising a plurality of films for a patch support according to any one of claims 1 to 8 laminated. 請求項1〜8のいずれか1項に記載された貼付剤支持体用フィルムの両面又は片面に、粘着剤層と剥離ライナー層とをこの順に積層した貼付剤。   A patch comprising an adhesive layer and a release liner layer laminated in this order on both sides or one side of the film for patch support according to any one of claims 1 to 8. 請求項9又は請求項10に記載された積層体の両面又は片面に、粘着剤層と剥離ライナー層とをこの順に積層した貼付剤。   An adhesive patch comprising a pressure-sensitive adhesive layer and a release liner layer laminated in this order on both sides or one side of the laminate according to claim 9 or 10.
JP2018197371A 2018-10-19 2018-10-19 Adhesive backing film, laminate and adhesive Active JP7275527B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018197371A JP7275527B2 (en) 2018-10-19 2018-10-19 Adhesive backing film, laminate and adhesive

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018197371A JP7275527B2 (en) 2018-10-19 2018-10-19 Adhesive backing film, laminate and adhesive

Publications (2)

Publication Number Publication Date
JP2020063221A true JP2020063221A (en) 2020-04-23
JP7275527B2 JP7275527B2 (en) 2023-05-18

Family

ID=70386778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018197371A Active JP7275527B2 (en) 2018-10-19 2018-10-19 Adhesive backing film, laminate and adhesive

Country Status (1)

Country Link
JP (1) JP7275527B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237889A (en) * 1978-09-13 1980-12-09 Minnesota Mining And Manufacturing Company Diaper closure utilizing pressure-sensitive adhesive tape having textured foil backing
JPH08127531A (en) * 1994-10-28 1996-05-21 Bando Chem Ind Ltd Substrate for percutaneously administering medicine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237889A (en) * 1978-09-13 1980-12-09 Minnesota Mining And Manufacturing Company Diaper closure utilizing pressure-sensitive adhesive tape having textured foil backing
JPH08127531A (en) * 1994-10-28 1996-05-21 Bando Chem Ind Ltd Substrate for percutaneously administering medicine

Also Published As

Publication number Publication date
JP7275527B2 (en) 2023-05-18

Similar Documents

Publication Publication Date Title
EP3307843B1 (en) Article provided with adhesive layer and release layer
KR20050027980A (en) Methods for producing composite webs with reinforcing discrete polymeric regions
RU2296054C2 (en) Composite fabrics with the reinforcing polymeric areas and with the elastic polymeric areas
JP2019088765A (en) Support film for patch, laminate and patch
WO2010078065A1 (en) Co-extrusion die, method of extruding with the die, and extruded articles made therefrom
EP2237757B1 (en) Micro- and/or nano-structured packaging material
JP7268324B2 (en) Adhesive backing film, laminate and adhesive
JP2020063221A (en) Film for patch support body, laminated body, and patch
JP7326825B2 (en) Adhesive backing film, laminate, and adhesive
JP7322496B2 (en) Adhesive backing film and laminate
JP7459487B2 (en) Film for patch support, laminate, and patch
JP7326817B2 (en) Adhesive backing film, laminate and adhesive
JP7447434B2 (en) Patch support films, laminates, and patches
JP7383218B2 (en) Patch support films, laminates, and patches
US8628848B2 (en) Plastic filmic label and a use of a plastic film for a filmic label
JP2021181421A (en) Film for plaster support medium, laminate, and plaster
JP7322495B2 (en) Adhesive backing film, laminate and adhesive
JP7271906B2 (en) Adhesive backing film, laminate, adhesive patch, and method for producing laminate
JP7447438B2 (en) Patch support films, laminates and patches
JP2023170081A (en) Film, tape and adhesive patch using the same
JP2021161031A (en) Patch support film, laminate and patch
JP2022098961A (en) Patch support medium film, and patch comprising patch support medium film
JP2024014336A (en) Film, film body, and method for manufacturing the same
JP2022083209A (en) Film, tape using the same, and patch
JP3774935B2 (en) Method for producing easily peelable laminated sheet

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221227

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230404

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230417

R150 Certificate of patent or registration of utility model

Ref document number: 7275527

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150